https://www.neurologylive.com/view/rituximab-treatment-associated-reduced-relapse-rate-aqp4-igg-positive-nmosd-mogad
0
0
10/11/22 at 3:04pm
Organization
Neurologylive.com
42 words
0
Comments
A study using patient data from John Hopkins showed that rituximab treatment was associated with reduced annualized relapse rates in AQP4-IgG seropositive NMOSD and MOGAD.
You are the first to view
Create an account
or login to join the discussion